Kast, R.E.; Skuli, N.; Sardi, I.; Capanni, F.; Hessling, M.; Frosina, G.; Kast, A.P.; Karpel-Massler, G.; Halatsch, M.-E.
Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen. Brain Sci. 2018, 8, 203.
https://doi.org/10.3390/brainsci8120203
AMA Style
Kast RE, Skuli N, Sardi I, Capanni F, Hessling M, Frosina G, Kast AP, Karpel-Massler G, Halatsch M-E.
Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen. Brain Sciences. 2018; 8(12):203.
https://doi.org/10.3390/brainsci8120203
Chicago/Turabian Style
Kast, Richard E., Nicolas Skuli, Iacopo Sardi, Felix Capanni, Martin Hessling, Guido Frosina, Anton P. Kast, Georg Karpel-Massler, and Marc-Eric Halatsch.
2018. "Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen" Brain Sciences 8, no. 12: 203.
https://doi.org/10.3390/brainsci8120203
APA Style
Kast, R. E., Skuli, N., Sardi, I., Capanni, F., Hessling, M., Frosina, G., Kast, A. P., Karpel-Massler, G., & Halatsch, M.-E.
(2018). Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen. Brain Sciences, 8(12), 203.
https://doi.org/10.3390/brainsci8120203